Hapten Sciences, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Safety, Tolerability, and Dermal Reactogenicity Study of PDC-APB (NCT04853823) | Hapten Sciences, Inc. | 2021-11-01 |
Track Hapten Sciences, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.